Vir

Resistance mutations found in those receiving GSK and Vir’s monoclonal for Delta, new research shows
Endpoints
Fri, 03/11/22 - 10:43 am
COVID-19
GSK
Vir
monoclonal antibodies
Bluebird’s new gene therapy among three new EMA OKs ahead of FDA
Endpoints
Fri, 05/21/21 - 10:56 am
gene therapy
Bluebird Bio
EMA
GSK
Vir
COVID-19
Skysona
monoclonal antibodies
Bylvay